Pearls of Wisdom
Pearl Pathways expands and hires 3 new associates
Pearl Pathways releases press release The diverse backgrounds of our new teammates serve growing demands of Pearl Pathways' clients. FOR IMMEDIATE RELEASE INDIANAPOLIS, INDIANA –February 25, 2013- Pearl Pathways announces the recent hiring of Daphine Glowner, Gretchen...
FDA on board for the search for cheaper drug development process
Industry professionals, academics and FDA all agree that the cost of drug development is unsustainable, according a recent article on the San Francisco Business Times. To tackle the problem, FDA is looking at ways to change the drug development process. At the...
Small Business Administration’s writes final rules for the reauthorized SBIR and STTR
As of January 28, 2013 the US Small Business Innovation Research (SBIR) program is operating under a new set of rules drafted into the National Defense Authorization Act for the FY 2012. The redesigned platform will bring in smaller biopharma businesses and other...
FDA releases draft guidance on Alzheimer’s disease treatments
Last week, FDA released draft guidance entitled, “Alzheimer’s Disease: Developing Drugs for the Treatment of Early Stage Disease,” which addresses the FDA’s view regarding the selection of patients with early Alzheimer’s Disease (AD), or at risk patients for clinical...
Europe launches new drug discovery platform
The European Lead Factory, an international consortium of pharmaceutical companies, academia and research organizations has initiated a new platform to improve European drug discovery, per a recent article on pharmtech.com. In a five year time frame, the 30 partner...